About
CEVR Team
Careers
Read for the Registry
Contact Us
News & Events
News
Events
Publications
Projects
Databases
CEA Registry
GH CEA Registry
SPEC Database
Sponsorship
Sponsor login
Contact Us
News & Events
News
CEVR by the Numbers: 2025
Our first "By the Numbers" report shows CEVR's impressive research output during 2025:...
The Tufts-CEVR HEOR Leaders Survey: Perspectives on Organizational Support and Evidence Opportunities
The Tufts-CEVR HEOR Leaders Survey: Perspectives on Organizational Support and Evidence Opportunities Peter J. Neumann, ScD,a Grace Hatfield, BA,a Lu ...
The Tufts-CEVR HEOR Leaders Survey: Health Policy Challenges and Opportunities
The Tufts-CEVR HEOR Leaders Survey: Health Policy Challenges and Opportunities Peter J. Neumann, ScD,a Lu Shi, PhD.,a Grace Hatfield, BA,a Tom Hughes...
View All News Items
Events
2026 CEVR Annual Meeting
CEVR Participation at ISPOR EU 2025
CEVR Health Policy Seminar with Boshen Jiao, PhD, MPH
View All Events
Publications
Health Affairs Scholar
The timeliness of health plan drug coverage policy changes to FDA label revisions
Health Affairs Scholar
FDA approvals of specialty drugs, 2000-2024
JAMA Network Open
Drug Prices, Rebates, and Health Plan Coverage Restrictions
JMCP
Use of Clinical Outcome Assessments in Specialty Drug Coverage Policies
AJMC
Communication of Launch Prices by Drug Companies, 2022-2024
Health Affairs Forefront
Do Medicare’s IPAY 2027 Negotiated Drug Prices Reflect Value For Money?
Journal of Neuromuscular Disease
US Health Plan Coverage of Neuromuscular Disease Therapies: An Assessment of Policy Availability and Restrictions
Health Affairs Forefront
The ‘Pharm-To-Table’ Movement For Prescription Drugs: Promising Or Performative?
Medical Decision Making
When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013–2023
View All Publications
